FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter's supplemental NDA for Cardene IV (nicardipine hydrochloride), authorizing changes to the approved intravenous product under the supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CARDENE IV (nicardipine hydrochloride)

Snippet

SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)